Core Viewpoint - Hema Medical (03309.HK) announced a share buyback of 160,000 shares at a total cost of HKD 277,200, with a buyback price ranging from HKD 1.72 to HKD 1.74 per share [1] Company Summary - As of November 26, 2025, Hema Medical's stock closed at HKD 1.74, reflecting a 0.58% increase with a trading volume of 320,000 shares and a turnover of HKD 553,000 [1] - The market capitalization of Hema Medical is HKD 2.142 billion, ranking 15th in the medical services sector [1] Financial Metrics - Return on Equity (ROE): -6.36%, compared to the industry average of -0.02%, ranking 39th in the sector [1] - Market Capitalization: HKD 2.142 billion, while the industry average is HKD 7.938 billion, ranking 15th [1] - Revenue: HKD 1.935 billion, with the industry average at HKD 3.832 billion, ranking 15th [1] - Net Profit Margin: 5.95%, significantly better than the industry average of -843.36%, ranking 25th [1] - Gross Profit Margin: 31.12%, compared to the industry average of 39.76%, ranking 28th [1] - Debt Ratio: 29.8%, much lower than the industry average of 74.15%, ranking 21st [1]

Core Viewpoint - The company, XiMa Medical (03309), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company plans to repurchase 160,000 shares at a total cost of HKD 277,200 [1] - The buyback price per share ranges from HKD 1.72 to HKD 1.74 [1]

Core Viewpoint - The company, Hema Medical (03309), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will repurchase 160,000 shares at a total cost of HKD 277,200 [1] - The buyback price per share ranges from HKD 1.72 to HKD 1.74 [1] - The buyback is scheduled to take place on November 26, 2025 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 希瑪醫療控股有限公司 呈交日期： 2025年11月26日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 03309 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | | 佔有關事件前的現有已發 | | | 每股發行/出售價 ...

Core Viewpoint - The company, Hema Medical (03309), announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will spend HKD 344,000 to repurchase 200,000 shares [1]

Group 1 - The company, XiMa Medical (03309), announced a share buyback plan to repurchase 200,000 shares at a cost of HKD 344,000 [1]

Core Viewpoint - Hema Medical (03309.HK) announced a share buyback of 200,000 shares at a cost of HKD 344,000 on November 25 [1] Group 1 - The company is actively engaging in share repurchase to potentially enhance shareholder value [1] - The buyback reflects the company's confidence in its financial position and future prospects [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 第 2 頁 共 13 頁 v 1.3.0 表格類別： 股票 狀態： 新提交 公司名稱： 希瑪醫療控股有限公司 呈交日期： 2025年11月25日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 03309 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | | | 佔有關 ...

Summary of Key Points Core Viewpoint - A total of 36 companies conducted share buybacks on November 24, 2025, with Tencent Holdings (00700) leading in both the number of shares repurchased and the total amount spent on buybacks. Group 1: Buyback Details - Tencent Holdings (00700) repurchased 1.022 million shares for a total of 636 million yuan, representing 0.825% of its total share capital for the year [1][2]. - China COSCO Shipping (01919) repurchased 3 million shares for 40.35 million yuan, accounting for 1.604% of its total share capital [2]. - China International Marine Containers (02039) repurchased 4.8904 million shares for 35.9467 million yuan, which is 1.530% of its total share capital [2]. Group 2: Other Notable Buybacks - China Feihe (06186) repurchased 7.233 million shares for 29.9668 million yuan, representing 1.969% of its total share capital [2]. - Sinopec Limited (00386) repurchased 4.054 million shares for 17.7861 million yuan, which is 0.150% of its total share capital [2]. - Pacific Basin Shipping (02343) repurchased 5 million shares for 12.757 million yuan, accounting for 1.555% of its total share capital [2]. Group 3: Smaller Buybacks - MONGOL MINING (00975) repurchased 390,000 shares for 3.6551 million yuan, which is 0.124% of its total share capital [2]. - Miniso Group (09896) repurchased 866,800 shares for 31.938 million yuan, representing 0.372% of its total share capital [2]. - Weigao Group (01066) repurchased 40,000 shares for 211,600 yuan, accounting for 4.379% of its total share capital [3].

Group 1 - The company, 希玛医疗 (03309), announced a share buyback plan to repurchase 200,000 shares at a cost of HKD 342,400 on November 24, 2025 [1]